Navigation Links
Leslie Zacks Joins Arbor Pharmaceuticals as General Counsel and Chief Compliance Officer
Date:2/21/2012

ATLANTA, Feb. 21, 2012 /PRNewswire/ -- Arbor Pharmaceuticals, a specialty pharmaceutical company based in Atlanta, GA, announced today that Leslie Zacks has joined the company as General Counsel and Chief Compliance Officer.  Mr. Zacks has a distinguished legal career and most recently held positions of increasing responsibility at Shionogi Pharma, Inc. (previously Sciele Pharma).  While at Shionogi, Leslie built the company's legal department and served on the company's executive leadership team where he was responsible for all legal, IP and compliance functions.

Mr. Zacks has been a practicing attorney in Atlanta, Georgia since 1994.  He was the Executive Vice President, General Counsel and Chief Compliance Officer at Shionogi Pharma, Inc. from 2004-2010.  From 2002 to 2004, Mr. Zacks worked at Hunton & Williams, LLP where he was a partner in the Intellectual Property Litigation department.  Mr. Zacks is a registered patent attorney who has held associate positions at Powell, Goldstein, Frazer & Murphy, LLP (now Bryan Cave, LLP) and at Carlock, Copeland and Stair, LLP.  Mr. Zacks holds a J.D. and a B.A. in English from the University of Florida.

Ed Schutter, President and CEO of Arbor, commented, "We are pleased that Leslie has joined Arbor in this significant role for the company.  Leslie has deep experience in patent law, mergers and acquisitions, compliance, and in many other key areas critical to Arbor as we continue our significant growth."

Mr. Zacks added, "I am pleased to be joining Arbor at this important point in the company's growth.  The company is well positioned to execute on its plan, and I look forward to building on Arbor's success in my new role."

About Arbor Pharmaceuticals, Inc.

Arbor Pharmaceuticals, headquartered in Atlanta, Georgia, is a specialty pharmaceutical company currently focused on the cardiovascular and pediatric markets. The company intends to become a leading specialty pharmaceutical company by actively licensing, developing and commercializing late-stage products for specialty focused conditions. Arbor currently markets multiple NDA and ANDA approved products with several more in development.

For more information regarding Arbor Pharmaceuticals or any of its products, visit www.arborpharma.com or send email inquiries to info@arborpharma.com.  


'/>"/>
SOURCE Arbor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
2. Zacks Rates CardioGenics Outperform With Six-Month Target of $1.22
3. Zacks Investment Research Initiates Coverage on Viral Genetics
4. Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals
5. The Zacks Analyst Blog Highlights: Pfizer, Bristol - Myers Squibb, Eli Lilly, Forest Laboratories and Abbott Laboratories
6. Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo
7. Zacks Releases Four Powerful Buy Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver
8. The Zacks Analyst Blog Highlights: UnitedHealth Group, Aetna, WellPoint, CIGNA and Wright Medical Group
9. Zacks Voice of the People highlights opportunities with Walgreen, Occidental Petroleum and Brown & Brown
10. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
11. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Allergy Diagnostics Market: Scope and ... that are used to determine the presence of ... drugs etc. in the samples by determining the ... The report on global allergy diagnostics market, analyzes ... The report consists of an executive summary that ...
(Date:12/8/2016)... , Dec 8, 2016 Research and Markets has ... report to their offering. ... This report analyzes the worldwide markets for Endodontic ... Canada , Japan , Europe ... and Rest of World. Annual estimates and forecasts are provided for ...
(Date:12/8/2016)... Mederi Therapeutics Inc . anunciou aprovação regulatória, pela CFDA, e lançamento de produto ... gastroesofágico (DRGE). Foto -  http://photos.prnewswire.com/prnh/20161207/446903 ... ... performed and broadcast during the Chinese Congress of Digestive Endoscopy, by Professor Jun ... , , ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... 2016 , ... The Justin Veatch Fund announced Thursday that ... film Whispering Spirits and its discussion guide for use by all of ... in the war against teen drug abuse. NCADD is the oldest anti-addiction advocacy ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical Center ... NY, on December 3rd, to benefit Holy Name Medical Center's programs and services. ... raised over $1 million - the largest event in the Center's history, both ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... become Quality Insights beginning January 1, 2017. The name change aligns the ... to measuring and improving health care quality. , “We are very proud of ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate that ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand ... “What’s In Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety ... dental implant and prosthetic market in the U.S. is projected to reach $6.4 billion ...
Breaking Medicine News(10 mins):